A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers

NCT01371175 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
115
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

International AIDS Vaccine Initiative

Collaborators